Related Experiment Videos
Promotion of peripheral axonopathies by certain esterase inhibitors
Abstract:
Certain esterase inhibitors were found to exacerbate the clinical signs of polyneuropathy caused by various neurotoxic compounds and to delay the recovery from nerve crush. This phenomenon is referred to as promotion of axonopathies. The molecular target of promotion has not yet been identified. However, all known promoters are also inhibitors of neuropathy target esterase (NTE), the putative target of organophosphate neuropathy, but it has been shown that the target of promotion is unlikely to be NTE. Available data suggest that promoters might affect a target and a mechanism present in the nervous system that is not activated by axonal lesions. Promotion may be important to understand the physiological mechanism of nerve damage and repair. This finding also implies a changing perspective for the risk assessment of exposures to esterase inhibitors, some of which are used as pesticides and might be promoters.
Insights
Certain esterase inhibitors worsen nerve damage and delay recovery, a process called promotion of axonopathies. The exact molecular target remains unknown, but it
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- Certain esterase inhibitors can worsen clinical signs of polyneuropathy and delay nerve crush recovery.
- This exacerbation phenomenon is termed promotion of axonopathies.
- The molecular target driving this promotion remains unidentified.
Purpose of the Study:
- To investigate the phenomenon of promotion of axonopathies.
- To explore potential molecular targets and mechanisms involved in nerve damage promotion.
- To assess the implications for risk assessment of esterase inhibitors.
Main Methods:
- Review of existing data on esterase inhibitors and their effects on neuropathy.
- Analysis of the relationship between known promoters and neuropathy target esterase (NTE) inhibition.
- Hypothesizing about potential targets not activated by axonal lesions.
Main Results:
- Esterase inhibitors were observed to promote axonopathies, worsening nerve damage and delaying recovery.
- While known promoters inhibit neuropathy target esterase (NTE), NTE is unlikely to be the target of promotion.
- Data suggest promoters may act on a nervous system target/mechanism not triggered by axonal injury.
Conclusions:
- Promotion of axonopathies is a distinct phenomenon potentially mediated by a novel molecular target.
- Understanding promotion is crucial for elucidating nerve damage and repair mechanisms.
- Findings necessitate a re-evaluation of risk assessment for esterase inhibitors, including pesticides.